FDA regulator examines AI'sgrowing influence in cardiology - Cardiovascular Business
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the …
Read the original at cardiovascularbusiness.com ↗
- Topics
- HealthcareRegulation & Policy
- Mentions
- FDA
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”